GLORIA

GEOMAR Library Ocean Research Information Access

X

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Israr, Muhammad  (4)
  • Unknown  (4)
Material
Publisher
Person/Organisation
Language
  • Unknown  (4)
Years
  • 1
    Online Resource
    Online Resource
    Visual Results of Intravitreal Bevacizumab (Avastin) Treatment for Branch Retinal Vein Occlusion a Multi Center Study
    Lahore Medical and Dental College ; 2023
    In:  Pakistan Journal of Medical and Health Sciences Vol. 17, No. 2 ( 2023-03-15), p. 811-813
    Details
    In: Pakistan Journal of Medical and Health Sciences, Lahore Medical and Dental College, Vol. 17, No. 2 ( 2023-03-15), p. 811-813
    Abstract: Objective: To evaluate the visual outcomes in patients with branch retinal vein obstruction after intravitreal bevacizumab (Avastin) injection. Study Location and Duration:, Department of Ophthalmology Abaseen hospital and Khyber medical center Peshawar from January 2019 to January 2022 both department conducted this multi-center study. Methodology: Patients with BRVO received at least one intravitreal Bevacizumab (Avastin) injection of 1.25 mg in 0.05 ml. Snellen visual acuity tests, Fundus Fluorescein Angiography (FFA), and Optical Coherence Tomography were used to assess the patients (OCT). A complete eye exam was conducted before treatment began, and monthly follow-up examinations were scheduled for the following six months. Results: The total number of patients and eyes was 78, with a mean age of 60. (SD 15.1). The average number of Intravitreal bevacizumab (Avastin) injections administered to patients was four (SD 1.40) per eye. There were no negative consequences observed. Before treatment, the average central macular thickness was 568 microns, but after three months it was only 370 microns (p0.001), and by six months it had decreased to 290 microns. Three months later, the average acuity was much better than at the start (p=0.001), with log MAR = 0.30 (SD 0.22). During the most recent 6-month follow-up, the mean visual acuity was log MAR = 0.40 (SD 0.23), better than the baseline value (p 0.001). Overall, 44 eyes showed an improvement in their vision. Conclusion: Intravitreal Bevacizumab intravitreally for branch retinal vein occlusion improves vision. Bevacizumab intravitreally enhances visual acuity, macular edema, and ischemia. Bevacizumab reduces the risk of vision-threatening vitreous hemorrhage and neovascularization. Hence, Bevacizumab improves vision and treats branch retinal vein occlusion effectively. Keywords: Intravitreal Bevacizumab (Avastin), Branch Retinal Vein Occlusion (BRVO), Visual Acuity Improvement, Macular Ischemia Relief. Retinal Neovascularization Reduction
    Type of Medium: Online Resource
    URL: Issue
    URL: Journal
    URL: Article
    DOI: 10.53350/pjmhs2023172
    DOI: 10.53350/pjmhs202317
    DOI: 10.53350/pjmhs2023172811
    Language: Unknown
    Publisher: Lahore Medical and Dental College
    Publication Date: 2023
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 2
    Online Resource
    Online Resource
    The Genetics and Clinical Presentation of Retinitis Pigmentosa A Tertiary Care Hospital Study
    Lahore Medical and Dental College ; 2022
    In:  Pakistan Journal of Medical and Health Sciences Vol. 16, No. 11 ( 2022-11-30), p. 799-801
    Details
    In: Pakistan Journal of Medical and Health Sciences, Lahore Medical and Dental College, Vol. 16, No. 11 ( 2022-11-30), p. 799-801
    Abstract: Objective: This study aims to analyze the retinitis pigmentosa patients' Clinical Presentation and inheritance patterns. Research conducted at the tertiary care hospital Material and methods: this tertiary care hospital study was carried out at a level I trauma center between 05 January 2018 to 05 January 2021. fifty-six patients and members of their families underwent an ophthalmic evaluation to help identify those with the condition and define its phenotype. The family tree was traced. Several relatives also had optical gheremco tomography and fundus photography. Results: at Presentation, 52 eyes (47%) were judged to be legally blind, whereas 38 (32%) had some degree of visual impairment. The visual field was narrowed in 22 instances ( 40%) due to the brightness of the interaction. In terms of inheritance patterns, we discovered that three cases were autosomal dominant (4%), 39 cases were autosomal recessive (70%), and three cases were x-linked (6%). Of the total cases, 11 (20%) were isolated incidents. There were 48 patients with a conventional retinitis pigmentosa image (86%) and eight patients with an unusual RP picture (12%), including three instances of pericentric RP (5%), 3 cases of Usher's disease (4%) and 1 case of retinitis punctata albescence (2%) bardet-biedl were identified in a single patient. Conclusions: Retinitis Pigmentosa Patients Have A Very Significant Risk Of Becoming Blind. Autosomal Recessive sporadically follows the Most Prevalent Pattern Of Inheritance. Early Detection Of Retinitis Pigmentosa Is Important In Preventing Blindness From The Disease, As Is Encouraging Patients To Forego Marriages To First Cousins. Keywords: Genetics and Clinical, Presentation, Retinitis Pigmentosa, kpc
    Type of Medium: Online Resource
    URL: Issue
    URL: Journal
    URL: Article
    DOI: 10.53350/pjmhs20221611
    DOI: 10.53350/pjmhs202216
    DOI: 10.53350/pjmhs20221611799
    Language: Unknown
    Publisher: Lahore Medical and Dental College
    Publication Date: 2022
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 3
    Online Resource
    Online Resource
    Patients with Ethambutol-Induced Ocular Toxicity Receiving "Directly Observed Treated Short-Course"
    Lahore Medical and Dental College ; 2023
    In:  Pakistan Journal of Medical and Health Sciences Vol. 17, No. 2 ( 2023-03-15), p. 814-816
    Details
    In: Pakistan Journal of Medical and Health Sciences, Lahore Medical and Dental College, Vol. 17, No. 2 ( 2023-03-15), p. 814-816
    Abstract: Objective: Determine the total number of Category-1 patients with ocular toxicity from Ethambutol after DOTS therapy. Methodology: This study conducted in department of Ophthalmology of abaseen hospital and Khyber medical center Peshawar over the one year, from May 2021 to April 2022 included Category-1 TB patients (both genders) aged 14 and 65 who had normal ocular parameters on an ophthalmological examination when starting DOTS treatment. The frequency of any vision change, optical symptom, including color vision, contrast sensitivity while receiving Ethambutol medication was examined in 240 eyes (120 patients). At the end of the first month and again at the end of the second month of therapy, Each patient's compliance with Ethambutol was examined, and all tests for ocular toxicity were repeated for each chosen patient. The study did not include patients in category-2 with positive sputum smears who had relapsed, had therapy fail, or was getting treatment after a break in treatment. Results: Out of 120 patients (240 eyes), 62 (51.6%) of them were male, and 58 (48.4%) of them were female patients. After a month, there was no sign of ocular toxicity. Ocular toxicity, on the other hand, appeared in 3 (2.5%) of the patients after the second month. Moreover, these three patients showed decreased visual acuity, poor color vision, decreased contrast sensitivity, and optic disc abnormalities. Conclusion: Patients with tuberculosis who use Ethambutol are at risk of developing ocular toxicity. As a result, it is essential to identify visual symptoms and signs as soon as possible to avoid unnecessary diagnostic delays and maybe irreversible vision loss. Keywords: Tuberculosis, Color Vision, Contrast Sensitivity, Optic Disc, Ethambutol-induced ocular toxicity, visual acuity, treatment strategies
    Type of Medium: Online Resource
    URL: Issue
    URL: Journal
    URL: Article
    DOI: 10.53350/pjmhs2023172
    DOI: 10.53350/pjmhs202317
    DOI: 10.53350/pjmhs2023172814
    Language: Unknown
    Publisher: Lahore Medical and Dental College
    Publication Date: 2023
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
  • 4
    Online Resource
    Online Resource
    Diabetic Retinopathy Prevalence in Patients with Established Diabetes Mellitus:A tertiary Care Hospital Study
    Lahore Medical and Dental College ; 2022
    In:  Pakistan Journal of Medical and Health Sciences Vol. 16, No. 11 ( 2022-11-30), p. 795-796
    Details
    In: Pakistan Journal of Medical and Health Sciences, Lahore Medical and Dental College, Vol. 16, No. 11 ( 2022-11-30), p. 795-796
    Abstract: Background: Diabetic retinopathy is one of the microvascular consequences of this metabolic disorder. Objectives: To establish a clear conclusion on the Prevalence of diabetic retinopathy in those who have already been diagnosed with diabetes. Methods: This was a tertiary care hospital study performed at the Peshawar ophthalmology outdoor clinic. The research period for this article was from 01 June 2020 to 05 December 2020. Male and female patients with diabetes mellitus comprised 86 participants in this research. Fundoscopy was performed on all patients in the medical clinic to check for diabetic retinopathy. Results: average age was 55.099±6.20 years, the Duration of diabetes was 09.29±03.62 years, and the average weight was 85.061±07.55Kg. There were 67% male patients and 33% female ones One-third of diabetic patients were found to have retinopathy. Conclusion: Diabetic retinopathy, length of time with diabetes, and diabetes mellitus are all relevant terms. Keywords: diabetes retinopathy, diabetes mellitus, Duration of diabetes
    Type of Medium: Online Resource
    URL: Issue
    URL: Journal
    URL: Article
    DOI: 10.53350/pjmhs20221611
    DOI: 10.53350/pjmhs202216
    DOI: 10.53350/pjmhs20221611795
    Language: Unknown
    Publisher: Lahore Medical and Dental College
    Publication Date: 2022
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
    Online Resource
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...